- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Metastatic castration-resistant prostate cancer
Total 89084 results
-
European Institute of OncologyRecruitingCastration-resistant Prostate CancerItaly
-
DualityBio Inc.RecruitingAdvanced Solid TumorsUnited States, Australia
-
DualityBio Inc.Recruiting
-
Istituto Scientifico Romagnolo per lo Studio e...BayerRecruitingMetastatic Castration-resistant Prostate CancerItaly
-
ExelixisTakeda; Roche-GenentechActive, not recruitingMetastatic Prostate Cancer | Prostate AdenocarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Russian Federation, Singapore, Spain, ... and more
-
Sorrento Therapeutics, Inc.SuspendedProstate Cancer | Prostate Cancer MetastaticUnited States
-
Fortis Therapeutics, Inc.CompletedProstate Cancer MetastaticUnited States
-
AstraZenecaMerck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate CancerBelgium, France, Italy, Netherlands, Poland, United States, Canada, Czechia, Russian Federation, United Kingdom, Spain
-
Bellicum PharmaceuticalsSuspendedMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
UNICANCERCompleted
-
University of Alabama at BirminghamSanofi; Astellas Pharma IncWithdrawn
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Innocrin PharmaceuticalProstate Cancer Foundation; Prostate Cancer Clinical Trials ConsortiumCompleted
-
Innocrin PharmaceuticalNational Cancer Institute (NCI)Completed
-
Emmanuel Antonarakis, MDMillennium Pharmaceuticals, Inc.WithdrawnProstate Cancer | Castration-resistant Prostate CancerUnited States
-
Canadian Cancer Trials GroupCanadian Institutes of Health Research (CIHR)Not yet recruitingMetastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer
-
Medical University of ViennaLund University; Ziekenhuis Netwerk Antwerpen (ZNA); St. Antonius Hospital; Azienda... and other collaboratorsNot yet recruitingProstate Cancer | Prostate Cancer Metastatic | Oligometastasis | Prostate Neoplasm | Oligometastatic Disease | Prostate Cancer Metastatic to Bone
-
Paul ViscuseNot yet recruitingMetastatic Prostate Cancer | Castrate Sensitive Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Not yet recruitingMalignant Solid Neoplasm | Breast Carcinoma | Metastatic Prostate Carcinoma | Ovarian Carcinoma | Triple-Negative Breast Carcinoma | Male Breast Carcinoma | Pancreatic Exocrine Neoplasm | Stage IVB Prostate Cancer American Joint Committee on Cancer v8United States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyNot yet recruitingAdvanced Solid TumorUnited States, Germany
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingMetastatic Castration-resistant Prostate CancerSwitzerland
-
Fusion Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
858 Therapeutics, Inc.RecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Advanced or Metastatic Solid Tumors | ER+ Breast Cancer | Castrate Resistant Prostate Cancer | BRCA MutationUnited States
-
Debiopharm International SARecruitingProstate CancerUnited States
-
Qian QinJanssen, LP; UT Southwestern Comprehensive Cancer CenterNot yet recruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | CHEK2 Gene Mutation | FANCA Gene Mutation | RAD51B Gene Mutation | RAD54L Gene Mutation | Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Deleterious HRR Gene Mutation
-
Peking University First HospitalNot yet recruiting
-
Norroy Bioscience Co., LTDRecruitingMetastatic Castration-resistant Prostate CancerChina
-
AstraZenecaMerck Sharp & Dohme LLCRecruitingMetastatic Castration-resistant Prostate CancerGermany
-
Institut de cancérologie Strasbourg EuropeContinuum Plus Santé; Plateforme nationale qualité de vie et cancer; WeShareRecruitingBreast Neoplasms | Lung Neoplasms | Prostatic Neoplasms | Colorectal NeoplasmsFrance
-
Mayo ClinicNot yet recruitingRecurrent Prostate Cancer | Castration-resistant Prostate Cancer | Stage IVB Prostate Cancer AJCC v8 | Recurrent Castration-Sensitive Prostate CarcinomaUnited States
-
Novartis PharmaceuticalsNot yet recruitingMetastatic Neuroendocrine Prostate Cancer
-
The First Affiliated Hospital of Xiamen UniversityRecruitingMetastatic Castration-resistant Prostate Cancer, mCRPCChina
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms, Castration-ResistantIsrael, Taiwan, Australia
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Therapy, Directly ObservedChina
-
SL VAXiGENRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)Korea, Republic of
-
University Hospital, Basel, SwitzerlandNot yet recruitingCastration-resistant Prostate CancerSwitzerland
-
Nuvation Bio Inc.RecruitingPancreatic Cancer | Advanced Solid Tumor | HER2-negative Breast Cancer | Metastatic Castration-resistant Prostate Cancer (mCRPC) | Platinum-resistant Ovarian Cancer (PROC)United States
-
Fondazione del Piemonte per l'OncologiaRecruiting
-
BayerNot yet recruitingNon-metastatic Castration-resistant Prostate Cancer | Metastatic Hormone-sensitive Prostate CancerKorea, Republic of
-
Rohan GarjeJanssen Scientific Affairs, LLCNot yet recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
University College, LondonNovartis; Cancer Research UK; Janssen Pharmaceutica NVNot yet recruiting
-
AbbVieRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Israel
-
Pedro Barata, MD, MScESSA Pharma Inc.Not yet recruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-sensitive Prostate Cancer (mHSPC)United States
-
Dana-Farber Cancer InstituteNovartisRecruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Roswell Park Cancer InstituteRecruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
RenJi HospitalRecruiting
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsNot yet recruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
AstraZenecaRecruitingMetastatic Prostate CancerUnited States, Australia
-
Erasmus Medical CenterRecruitingProstate Cancer MetastaticNetherlands